Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology.

Grabowski GA, Golembo M, Shaaltiel Y.

Mol Genet Metab. 2014 May;112(1):1-8. doi: 10.1016/j.ymgme.2014.02.011. Epub 2014 Mar 2. Review.

PMID:
24630271
2.

Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems.

Tekoah Y, Tzaban S, Kizhner T, Hainrichson M, Gantman A, Golembo M, Aviezer D, Shaaltiel Y.

Biosci Rep. 2013 Sep 25;33(5). pii: e00071. doi: 10.1042/BSR20130081.

3.

Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia--genetic short limbed dwarfism.

Aviezer D, Golembo M, Yayon A.

Curr Drug Targets. 2003 Jul;4(5):353-65. Review.

PMID:
12816345
6.

EGF receptor signaling induces pointed P1 transcription and inactivates Yan protein in the Drosophila embryonic ventral ectoderm.

Gabay L, Scholz H, Golembo M, Klaes A, Shilo BZ, Klämbt C.

Development. 1996 Nov;122(11):3355-62.

7.

Argos transcription is induced by the Drosophila EGF receptor pathway to form an inhibitory feedback loop.

Golembo M, Schweitzer R, Freeman M, Shilo BZ.

Development. 1996 Jan;122(1):223-30.

8.

Cloning and characterization of the human GnRH receptor.

Chi L, Zhou W, Prikhozhan A, Flanagan C, Davidson JS, Golembo M, Illing N, Millar RP, Sealfon SC.

Mol Cell Endocrinol. 1993 Feb;91(1-2):R1-6.

PMID:
8386108
9.

IL-3 facilitates lymphocyte hexose transport by enhancing the intrinsic activity of the transport system.

Nefesh I, Bauskin AR, Alkalay I, Golembo M, Ben-Neriah Y.

Int Immunol. 1991 Aug;3(8):827-31.

PMID:
1911550

Supplemental Content

Loading ...
Support Center